Hypotension Probability Index in Anesthesia
Primary Purpose
Hip Disease, Hypotension, Surgery
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Hypotension probability index (HPI)
Sponsored by
About this trial
This is an interventional treatment trial for Hip Disease focused on measuring goal directed management
Eligibility Criteria
Inclusion Criteria:
Patients undergoing hip-replacement
- General anesthesia
- Age ≥ 18 years
Exclusion Criteria:
Participation in another (interventional) study
- Pregnancy and nursing mothers
- Surgery without controlled ventilation
- ASA > III
- Contraindication for invasive blood pressure monitoring
- Renal insufficiency KDIGO Stadium ≥ 2
- Coagulation disorder
Sites / Locations
- Michael Sander
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intervention arm
Control arm
Arm Description
HPI monitoring to predict hypotension
blinded HPI monitoring
Outcomes
Primary Outcome Measures
Episode of hypotension
The aim of the study is to investigate whether a goal directed treatment according to the Hypotension Probability Index compared to standard care can reduce the incidence of intraoperative hypotension in patients with hip-replacement. As primary endpoints frequency (n)/h, absolute and relative duration (t [min]/% of total anesthesia time) of intraoperative hypotension were defined for this study.
Secondary Outcome Measures
Changes of fluid management
Amount of of intravenous fluids (ml of crystalloids, ml of colloids)
Changes of catecholamine management
Dosage of vasopressors and inotropes (µg)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03663270
Brief Title
Hypotension Probability Index in Anesthesia
Official Title
Influence of the "Hypotension Probability Index" on the Number and Duration of Intraoperative Hypotension in Primary Hip Endoprosthetic Replacement
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
June 22, 2017 (Actual)
Primary Completion Date
June 30, 2018 (Actual)
Study Completion Date
October 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Giessen
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to investigate the value of the Hypotension Probability Index in reducing intraoperative hypotension in patients with primary hip replacement. The measurement of the blood pressure was and is of great interest for the treating physician/anesthesiologist to optimize the peri- and postoperative patients outcome. The non-invasive measurement can scale the blood pressure but not from heartbeat-to-heartbeat, what results in a loss of information. The invasive measurement by a placed catheter in an artery shows the blood pressure with information about the pulse wave form, the ascending angle, and makes it possible to detect hemodynamic changes in a way the non-invasive blood pressure measurement is lacking. The additional informations of the monitoring and a
Detailed Description
Study design The study is designed as a single center randomized prospective interventional trial comparing goal directed hemodynamic management using HPI compared to standard care.
Subcenter University hospital of Giessen, Department of Anesthesiology, Operative Intensive Care and Pain Therapy (Study team: Dres. med. Christian Koch, Emmanuel Schneck, Thomas Zajonz, Dagmar Schulte, Fabian Edinger, Sophie Ruhrmann) 3.3 Study Population The study population is therefore divided into three groups.
Intervention group (optimization based on HPI) n=25
Control group (optimization based on standard monitoring without HPI) n=25
Inclusion Criteria
Patients undergoing hip-replacement
General anesthesia
Age ≥ 18 years
Exclusion criteria
Predefined exclusion criteria are:
Participation in another (interventional) study
Pregnancy and nursing mothers
Surgery without controlled ventilation
American Society of Anesthesiologists (ASA) score > III
Contraindication for invasive blood pressure monitoring
Renal insufficiency (Kidney Disease Improving Global Outcomes (KDIGO) score Stadium ≥ 2)
Coagulation disorder
Dropout Criteria None
Patient flow Patients are recruited before surgery after checking inclusion and exclusion criteria. Informed consent is obtained at this time. During this process also basic patients characteristics are obtained:
Age, sex, height, weight, ASA score
Pre-existing conditions (hypertension, state after myocardial infarction, coronary heart disease, peripheral arterial disease, renal failure, chronic obstructive pulmonary disease,diabetes)
Previous surgeries
Current medication
Laboratory results
Endpoints
Primary endpoint:
• Frequency (n)/h and Duration (t [min]/% of total anesthesia time) of intraoperative hypotension
Secondary endpoints:
Suspected reason for hypotension
Quantity of intravenous volume (crystalloids, colloids, blood products and salvage blood)
Type and dosage of vasopressors (epinephrine, norepinephrine, dobutamine)
Cardiac output, cardiac index (CO, CI)
Stroke volume/ stroke volume index (SV/ SVI)
Stroke volume variation (SVV)
Systemic vascular resistance (SVRI)
Heart rate (HR)
Blood pressure (BP)
Duration of surgery, duration of anesthesia
Blood loss
Transfusion rate
Net fluid intake
Additional outcome parameter
hospital length of stay
intensive care length of stay
duration of mechanical ventilation
hemoglobin level at the end of surgery
Data Processing Data collection is carried out consistently on pre-defined time-points in our electronic patient data management system (NarkoData, IMESO Company, Giessen, Germany) into a separated study database(Microsoft Excel). Patient data is transferred to the database as pseudonyms based on a random key method. The chart with the patient data and decrypting keys is kept in the study center for at least 15 years after the end of the study (publication). Data anonymization is intentionally not performed to give patients the option for data insight or deletion of their data in the future.
Data management and evaluation is performed by the study team.
Patient number and Biometrics The aim of the study is to show the benefit of early and automated monitoring of intraoperative hypotension index in order to support automatically registration of the approach of critical situations given as probability of occurrence of hypotension.
Benefit - Risk assessment Potential benefit Based on a continuous monitoring by additional monitoring system (HPI) an early detection of potential life threatening events is possible. This can result in an optimization of the patients' therapy and a better outcome.
Potential Risks The presented study is an interventional study. The potential risks are marginal. The usage of an arterial catheter is based on preexisting diseases, to monitor the blood pressure continuously. The risk of arterial injuries, infection, fistula etc. is minimal. The time points of blood samples for the study are in line with routine sampling. Based on this, there is no additional risk for the patient.
Benefit/ Risk analysis The benefit for the patients is additional monitoring, based on an additional monitoring device and the supervising study doctor, who can support the treating anesthesiologist with information in potentially critical situations. Thereby, it is possible to treat early goal-directed and possibly improve the patients outcome. Considering the potential benefits of the generated information for the patient in comparison to the expected risks, the beneficial effect is overbalanced.
The expected gain in knowledge from this study could be used for optimizing perioperative care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Disease, Hypotension, Surgery, Anesthesia
Keywords
goal directed management
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized two arm study with two groups
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Computer generated random list
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention arm
Arm Type
Active Comparator
Arm Description
HPI monitoring to predict hypotension
Arm Title
Control arm
Arm Type
No Intervention
Arm Description
blinded HPI monitoring
Intervention Type
Device
Intervention Name(s)
Hypotension probability index (HPI)
Intervention Description
The intervention group is managed with the HPI parameter to detect and possibly prevent hypotension during anaesthesia.
Primary Outcome Measure Information:
Title
Episode of hypotension
Description
The aim of the study is to investigate whether a goal directed treatment according to the Hypotension Probability Index compared to standard care can reduce the incidence of intraoperative hypotension in patients with hip-replacement. As primary endpoints frequency (n)/h, absolute and relative duration (t [min]/% of total anesthesia time) of intraoperative hypotension were defined for this study.
Time Frame
up to 18 months
Secondary Outcome Measure Information:
Title
Changes of fluid management
Description
Amount of of intravenous fluids (ml of crystalloids, ml of colloids)
Time Frame
up to 18 months
Title
Changes of catecholamine management
Description
Dosage of vasopressors and inotropes (µg)
Time Frame
up to 18 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing hip-replacement
General anesthesia
Age ≥ 18 years
Exclusion Criteria:
Participation in another (interventional) study
Pregnancy and nursing mothers
Surgery without controlled ventilation
ASA > III
Contraindication for invasive blood pressure monitoring
Renal insufficiency KDIGO Stadium ≥ 2
Coagulation disorder
Facility Information:
Facility Name
Michael Sander
City
Gießen
ZIP/Postal Code
35392
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
31784852
Citation
Schneck E, Schulte D, Habig L, Ruhrmann S, Edinger F, Markmann M, Habicher M, Rickert M, Koch C, Sander M. Hypotension Prediction Index based protocolized haemodynamic management reduces the incidence and duration of intraoperative hypotension in primary total hip arthroplasty: a single centre feasibility randomised blinded prospective interventional trial. J Clin Monit Comput. 2020 Dec;34(6):1149-1158. doi: 10.1007/s10877-019-00433-6. Epub 2019 Nov 29.
Results Reference
derived
Learn more about this trial
Hypotension Probability Index in Anesthesia
We'll reach out to this number within 24 hrs